Elisio Costa
Overview
Explore the profile of Elisio Costa including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
141
Citations
1747
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Portela D, Freitas A, Costa E, Giovannini M, Bousquet J, Almeida Fonseca J, et al.
J Med Internet Res
. 2025 Mar;
27:e51804.
PMID: 40063932
Background: Google Trends (GT) data have shown promising results as a complementary tool to classical surveillance approaches. However, GT data are not necessarily provided by a representative sample of patients...
2.
Koumpis A, Bamidis P, Costa E, Konstantinidis E
Front Med (Lausanne)
. 2025 Mar;
12:1567993.
PMID: 40061379
No abstract available.
3.
Midao L, Duarte M, Sampaio R, Almada M, Dias C, Paul C, et al.
JMIR Form Res
. 2025 Mar;
9:e51975.
PMID: 40053720
Background: Portugal is facing the challenge of population ageing, with a notable increase in the proportion of older individuals. This has positioned the country among those in Europe with a...
4.
Alcantara L, Figueiredo T, Costa E
Patient Prefer Adherence
. 2025 Mar;
19:503-526.
PMID: 40046563
Few interventions and programmes have proved to be effective in increasing therapeutic adherence. Numerous efforts have been made to identify key factors that significantly influence adherence. In older adults, non-adherence...
5.
Sousa H, Ribeiro O, Bartolo A, Rodrigues M, Costa E, Quental J, et al.
J Ren Care
. 2025 Mar;
51(1):e70012.
PMID: 40035453
Background: The 'Connected We St@nd' programme is an Internet-mediated self-management intervention that combines health education with psychosocial support, with evidenced feasibility and acceptability in haemodialysis. Objectives: To evaluate the clinical...
6.
Bonanno E, Figueiredo T, Mimoso I, Morgado M, Carrilho J, Midao L, et al.
J Clin Med
. 2025 Feb;
14(4).
PMID: 40004860
Polypharmacy, a common condition among the older population, is associated with adverse outcomes, including higher mortality, falls and hospitalization rates, adverse drug reactions, drug-drug interactions, medication nonadherence, and consequently increased...
7.
Ravselj D, Kerzic D, Tomazevic N, Umek L, Brezovar N, A Iahad N, et al.
PLoS One
. 2025 Feb;
20(2):e0315011.
PMID: 39908277
The paper presents the most comprehensive and large-scale global study to date on how higher education students perceived the use of ChatGPT in early 2024. With a sample of 23,218...
8.
Mimoso I, Figueiredo T, Midao L, Carrilho J, Henriques D, Alves S, et al.
Int J Environ Res Public Health
. 2025 Jan;
21(12.
PMID: 39767430
Digital therapeutics (DTx) are transforming healthcare delivery through personalised, evidence-based interventions that offer a cost-effective approach to health management. However, their widespread adoption faces significant barriers including privacy concerns, usability...
9.
Fassbender A, Donde S, Silva M, Friganovic A, Stievano A, Costa E, et al.
Ther Clin Risk Manag
. 2025 Jan;
20:939-954.
PMID: 39741688
Digital therapeutics (DTx) are an emerging medical therapy comprising evidence-based interventions that are regulatory approved for patient use, or are under development, for a variety of medical conditions, including hypertension,...
10.
Figueiredo T, Midao L, Carrilho J, Henriques D, Alves S, Duarte N, et al.
Front Med (Lausanne)
. 2024 Jul;
11:1418612.
PMID: 39050540
The increasing prevalence of dementia demands innovative solutions; however, existing technological products often lack tailored support for individuals living with this condition. The Living Lab approach, as a collaborative innovation...